BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 19 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,117 | -29.4% | 11,305 | -10.4% | 0.00% | – |
| Q2 2023 | $321,858 | +8.9% | 12,612 | -9.2% | 0.00% | – |
| Q1 2023 | $295,483 | -22.9% | 13,892 | +7.3% | 0.00% | – |
| Q4 2022 | $383,084 | -42.1% | 12,942 | -54.5% | 0.00% | – |
| Q3 2022 | $662,000 | +203.7% | 28,475 | +119.6% | 0.00% | – |
| Q2 2022 | $218,000 | -44.0% | 12,966 | +45.9% | 0.00% | – |
| Q1 2022 | $389,000 | +620.4% | 8,884 | +896.0% | 0.00% | – |
| Q4 2021 | $54,000 | +54.3% | 892 | +5.4% | 0.00% | – |
| Q3 2021 | $35,000 | -32.7% | 846 | -50.7% | 0.00% | – |
| Q2 2021 | $52,000 | +372.7% | 1,715 | +387.2% | 0.00% | – |
| Q1 2021 | $11,000 | +175.0% | 352 | +50.4% | 0.00% | – |
| Q4 2020 | $4,000 | -55.6% | 234 | -52.7% | 0.00% | – |
| Q3 2020 | $9,000 | -75.0% | 495 | -78.3% | 0.00% | – |
| Q2 2020 | $36,000 | +111.8% | 2,285 | +33.0% | 0.00% | – |
| Q2 2019 | $17,000 | – | 1,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,915,274 | $57,209,000 | 21.43% |
| Atlas Venture Advisors, Inc. | 612,696 | $18,301,000 | 3.38% |
| Logos Global Management LP | 800,000 | $23,896,000 | 2.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 | $58,484,000 | 1.28% |
| Ghost Tree Capital, LLC | 150,000 | $4,481,000 | 1.05% |
| Parkman Healthcare Partners LLC | 75,454 | $2,254,000 | 0.52% |
| MOODY ALDRICH PARTNERS LLC | 74,060 | $2,212,000 | 0.32% |
| Point72 Asset Management, L.P. | 1,577,493 | $47,120,000 | 0.22% |
| Eventide Asset Management | 411,838 | $12,302,000 | 0.18% |
| SAMLYN CAPITAL, LLC | 437,728 | $13,076,000 | 0.18% |